Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer
about
Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer: A systematic review and meta-analysis.Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapyUSP2a alters chemotherapeutic response by modulating redox.Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics.On the origins of the androgen receptor low molecular weight species.Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer.Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.Induction of reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cellsLow prostate concentration of lycopene is associated with development of prostate cancer in patients with high-grade prostatic intraepithelial neoplasiaThioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer.Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress.Activation of the LKB1‑SIK1 signaling pathway inhibits the TGF‑β‑mediated epithelial‑mesenchymal transition and apoptosis resistance of ovarian carcinoma cells.Application of novel targeting nanoparticles contrast agent combined with contrast-enhanced computed tomography during screening for early-phase gastric carcinoma.Alzheimer's disease is associated with prostate cancer: a population-based study.Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer.Efficacy of androgen deprivation therapy and the role of oxidative stress.Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variantsMixed lineage kinase-4 promotes gastric carcinoma tumorigenesis through suppression of the c-Jun N-terminal kinase signaling pathway
P2860
Q30245022-2CADFD8C-24C1-429A-B7A9-E4ABCCFC32DDQ35965415-73C27732-499C-45A6-83AF-355C5F64355AQ37211956-32B3E606-FE03-4F16-A582-F213AF407271Q38106640-9A6A4AC8-BFAA-4BD0-8A71-B5A2A5912343Q38122085-E55992D8-4AB0-46FA-90ED-8A01CB1F67FEQ38803264-BE3D4EFA-41BB-4564-AFE8-4C3D133CC950Q39003326-8C2A11D5-7E42-478B-AA94-F9F584CDEB0EQ39004481-AEF75044-1707-4248-B73A-32096FBB13D2Q39182893-EF0487DC-E8CF-48D4-91CA-7D6C4BCF1BEDQ41902097-77085B55-1BBD-4A39-B4AE-4AE03FB4408CQ46271330-A7CC70C8-0DD2-48DC-85D8-DFE18A3FA58DQ46434898-D35A6E19-72CF-4170-A7CB-456C657C2706Q49235662-F817436C-12C4-4996-ABCA-F1791D2F478FQ49259456-556CED2B-19F0-4393-926F-C13C3153ED7EQ50327083-49BEEBA5-9623-4A79-9A1F-E387EFBDDA84Q51712236-B7BA6848-B884-48E5-8F5F-7EB031BF7DA6Q55177134-B24B6CD9-92ED-45F6-9892-1A6AC1B55612Q58697074-C06F5301-D59B-4879-9910-5DE3EC19296FQ58733361-75E9ECDC-55EF-46C3-9BA3-88F79E618CF9
P2860
Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@ast
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@en
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@nl
type
label
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@ast
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@en
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@nl
prefLabel
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@ast
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@en
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@nl
P3181
P356
P1476
Pro-survival and anti-apoptoti ...... resistance in prostate cancer
@en
P2093
Akira Yokomizo
Seiji Naito
P304
P3181
P356
10.1530/ERC-12-0232
P407
P577
2012-11-09T00:00:00Z